These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 37294075)

  • 21. A tissue chip with integrated digital immunosensors: In situ brain endothelial barrier cytokine secretion monitoring.
    Su SH; Song Y; Stephens A; Situ M; McCloskey MC; McGrath JL; Andjelkovic AV; Singer BH; Kurabayashi K
    Biosens Bioelectron; 2023 Mar; 224():115030. PubMed ID: 36603283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model.
    Santa-Maria AR; Walter FR; Figueiredo R; Kincses A; Vigh JP; Heymans M; Culot M; Winter P; Gosselet F; Dér A; Deli MA
    J Cereb Blood Flow Metab; 2021 Sep; 41(9):2201-2215. PubMed ID: 33563079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Use of Sensors in Blood-Brain Barrier-on-a-Chip Devices: Current Practice and Future Directions.
    Kincses A; Vigh JP; Petrovszki D; Valkai S; Kocsis AE; Walter FR; Lin HY; Jan JS; Deli MA; Dér A
    Biosensors (Basel); 2023 Mar; 13(3):. PubMed ID: 36979569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Barrier Integrity Using a Two-Layered Microfluidic Device Mimicking the Blood-Brain Barrier.
    Kadry H; Cucullo L
    Methods Mol Biol; 2024; 2711():77-88. PubMed ID: 37776450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of the neurotoxicity of indoor airborne nanoparticles based on a 3D human blood-brain barrier chip.
    Li Y; Liu Y; Hu C; Chang Q; Deng Q; Yang X; Wu Y
    Environ Int; 2020 Oct; 143():105598. PubMed ID: 32622118
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Healthy and diseased placental barrier on-a-chip models suitable for standardized studies.
    Rabussier G; Bünter I; Bouwhuis J; Soragni C; van Zijp T; Ng CP; Domansky K; de Windt LJ; Vulto P; Murdoch CE; Bircsak KM; Lanz HL
    Acta Biomater; 2023 Jul; 164():363-376. PubMed ID: 37116636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood-brain barrier.
    Buzhdygan TP; DeOre BJ; Baldwin-Leclair A; Bullock TA; McGary HM; Khan JA; Razmpour R; Hale JF; Galie PA; Potula R; Andrews AM; Ramirez SH
    Neurobiol Dis; 2020 Dec; 146():105131. PubMed ID: 33053430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, Simulation, and Evaluation of Polymer-Based Microfluidic Devices via Computational Fluid Dynamics and Cell Culture "On-Chip".
    Bakuova N; Toktarkan S; Dyussembinov D; Azhibek D; Rakhymzhanov A; Kostas K; Kulsharova G
    Biosensors (Basel); 2023 Jul; 13(7):. PubMed ID: 37504152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organ-on-Chips for Studying Tissue Barriers: Standard Techniques and a Novel Method for Including Porous Membranes Within Microfluidic Devices.
    Ballerini M; Jouybar M; Mainardi A; Rasponi M; Ugolini GS
    Methods Mol Biol; 2022; 2373():21-38. PubMed ID: 34520004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blood-brain barrier (BBB)-on-a-chip: a promising breakthrough in brain disease research.
    Peng B; Hao S; Tong Z; Bai H; Pan S; Lim KL; Li L; Voelcker NH; Huang W
    Lab Chip; 2022 Sep; 22(19):3579-3602. PubMed ID: 36004771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human Blood-Brain Barrier on a Chip: Featuring Unique Multicellular Cooperation in Pathophysiology.
    Ahn SI; Kim Y
    Trends Biotechnol; 2021 Aug; 39(8):749-752. PubMed ID: 33602608
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-brain barrier on a chip.
    Chin E; Goh E
    Methods Cell Biol; 2018; 146():159-182. PubMed ID: 30037460
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Degenerative disease-on-a-chip: Developing microfluidic models for rapid availability of newer therapies.
    Jahagirdar D; Bangde P; Jain R; Dandekar P
    Biotechnol J; 2021 Oct; 16(10):e2100154. PubMed ID: 34390543
    [TBL] [Abstract][Full Text] [Related]  

  • 34. BBB-on-a-Chip: Modeling Functional Human Blood-Brain Barrier by Mimicking 3D Brain Angiogenesis Using Microfluidic Chip.
    Lee S; Chung M; Jeon NL
    Methods Mol Biol; 2022; 2492():251-263. PubMed ID: 35733049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Organ-On-A-Chip Technologies for Advanced Blood-Retinal Barrier Models.
    Ragelle H; Goncalves A; Kustermann S; Antonetti DA; Jayagopal A
    J Ocul Pharmacol Ther; 2020; 36(1):30-41. PubMed ID: 31140899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microfluidic blood-brain barrier model provides in vivo-like barrier properties for drug permeability screening.
    Wang YI; Abaci HE; Shuler ML
    Biotechnol Bioeng; 2017 Jan; 114(1):184-194. PubMed ID: 27399645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Organs-on-chips with integrated electrodes for trans-epithelial electrical resistance (TEER) measurements of human epithelial barrier function.
    Henry OYF; Villenave R; Cronce MJ; Leineweber WD; Benz MA; Ingber DE
    Lab Chip; 2017 Jun; 17(13):2264-2271. PubMed ID: 28598479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Numerical approach-based simulation to predict cerebrovascular shear stress in a blood-brain barrier organ-on-a-chip.
    Jeong S; Seo JH; Garud KS; Park SW; Lee MY
    Biosens Bioelectron; 2021 Jul; 183():113197. PubMed ID: 33819903
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Brain-on-a-chip: Recent advances in design and techniques for microfluidic models of the brain in health and disease.
    Amirifar L; Shamloo A; Nasiri R; de Barros NR; Wang ZZ; Unluturk BD; Libanori A; Ievglevskyi O; Diltemiz SE; Sances S; Balasingham I; Seidlits SK; Ashammakhi N
    Biomaterials; 2022 Jun; 285():121531. PubMed ID: 35533441
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chip-based human liver-intestine and liver-skin co-cultures--A first step toward systemic repeated dose substance testing in vitro.
    Maschmeyer I; Hasenberg T; Jaenicke A; Lindner M; Lorenz AK; Zech J; Garbe LA; Sonntag F; Hayden P; Ayehunie S; Lauster R; Marx U; Materne EM
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt A):77-87. PubMed ID: 25857839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.